news aktuell GmbHnews aktuell GmbH

Biomay AG: Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine


(Vienna, Austria): Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply chain for manufacturing of the Pfizer-BioNTech COVID-19 mRNA vaccine. Biomay is one of the manufacturers supplying BioNTech with the DNA template for the in-vitro transcription of their mRNA active ingredient.

The manufacturing agreement was initiated during the clinical development phase of the vaccine in Q1/2020. In the meantime, Biomay has become a formally qualified supplier for BioNTech. The scope of services includes process and analytical development, followed by GMP preparation of the cell bank, manufacturing of circular DNA plasmid and finally preparation of the linear DNA template.

In 2021, Biomay has produced and delivered multiple batches of released DNA template and supported the mRNA vaccine production thanks to this important manufacturing component, and the company will continue to do so throughout the year.

Hans Huber, Chief Executive Officer of Biomay, is pleased about Biomay cooperating with BioNTech on this globally essential project: “Biomay is proud to be making an active contribution to combating the coronavirus pandemic. Our staff are highly motivated and fully aware of the major responsibility associated with this cooperation. We would like to thank BioNTech for their trust in Biomay´s expertise. We have been able to demonstrate that our proprietary plasmid manufacturing platform is well suited to supply the required high quality and large volume of DNA template.”

About the Pfizer-BioNTech COVID-19 Vaccine

The Pfizer-BioNTech COVID-19 vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States (jointly with Pfizer), United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.

About Biomay

Biomay AG is a biopharmaceutical contract development and manufacturing organization (CDMO) with an international reach. Biomay is recognized as a supplier of plasmid DNA (pDNA), recombinant proteins and mRNA. Biomay´s clients include start-ups, midsize biotech companies and multinational enterprises, predominantly from Europe and the US. Beside the manufacturing of active ingredients and drug products according to standards of Good Manufacturing Practice (GMP), the company offers process and assay development as well as manufacturing of microbial cell banks.

Biomay is currently constructing a fully integrated biotech manufacturing plant in Aspern Seestadt, Vienna. This greenfield investment will exclusively be dedicated to Biomay´s biotech CDMO activities. Parallel manufacturing lines will allow Biomay to increase its capacities by a factor of 10 with respect to batch scale and bioreactor volumes (rounded up to ~ 1000 L). Biomay will move to its new facility in December this year, with GMP operations scheduled to start in Q1/2022.


About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

BMW Group: The BMW Group announces global partnership with the Bayerische Staatsoper. Expansion of long-term partnership is a contribution to social responsibility efforts and provides new impulses for the renowned Munich opera house8.6.2021 14:35:52 CEST | Press release

(Munich, Germany): Marking the year of the 50th anniversary of cultural commitment, the BMW Group is building up on its cooperation with the Bayerische Staatsoper by becoming the Global Partner. The automotive manufacturer and the opera house have been partners since 1997. On the occasion of their 25th anniversary and with Serge Dorny as designated General Manager and Vladimir Jurowski as designated General Music Director, collaborations such as Opera for all will continue while also focussing on the development of digital formats to reach a broader audience. The BMW Group leads the way as corporate citizen and contributes to social responsibility. As one of the world’s leading opera houses, the Bayerische Staatsoper looks back on a history of over 350 years and makes a major contribution to Munich’s reputation as one of the great international cultural capitals. In 1997, BMW and the Bayerische Staatsoper initiated Opera for all including the live broadcast of an opera and the open-air

CIIE: Join CIIE to embrace opportunities in Chinese market25.5.2021 13:37:06 CEST | Press release

(Shanghai, China): Are you still searching for the right gateway to enter the Chinese market? Are you looking to boost your sales activities and network with potential trade partners in China? Are you seeking more media exposure that costs little to nothing? The China International Import Expo (CIIE) may be just the perfect channel to help you achieve these goals. What is CIIE? The CIIE is the world's largest import expo and one of the top 10 business shows in the world. It is evolving to be a must-attend event for multinationals in every November in Shanghai. Why attend it? Firstly, its scale and breadth of industries. Last year, it covered 360,000 square meters, or about the size of 70 football fields. Secondly, high-quality participants and exhibits. 10,000 exhibitors attended the first three editions, including many Global Fortune 500 companies and industry leaders. More than 1,300 products and services have made their global or Chinese debuts over the past three expos. Thirdly, op

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom